IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
Andreas Hombach(University of Cologne), Hinrich Abken(Leibniz Association)
Cited by 96
Related Papers
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
|Cancer Research|2011|541
Magnetic CAR T cell purification using an anti-G4S linker antibody
|Journal of Immunological Methods|2024|3